Skip To Main Content
Lilly
Menu closed
Lilly
  • Account Login / Register
  • Medical Home
  • Medical Education
      • All Therapeutic Areas
        • Alopecia Areata
        • Atopic Dermatitis
        • Psoriasis
        • Diabetes
        • Hypoglycemia
        • Inflammatory Bowel Disease
        • Ulcerative Colitis
        • COVID-19
        • Headache Disorders
        • Neurodegeneration
        • Breast Cancer
        • Hematologic Cancer
        • Prostate Cancer
        • Axial Spondyloarthritis
        • Psoriatic Arthritis
        • Rheumatoid Arthritis
        • Resources
      • All Therapeutic Areas
        • Alopecia Areata
        • Atopic Dermatitis
        • Psoriasis
        • Diabetes
        • Hypoglycemia
        • Inflammatory Bowel Disease
        • Depression
        • Headache Disorders
        • Breast Cancer
        • Gastrointestinal Cancer
        • Oncology General
        • Osteoporosis
        • Rheumatoid Arthritis
        • Resources
  • Independent Medical Education
      • Alopecia Areata
      • Atopic Dermatitis
      • Psoriasis
    • Diabetes
      • Ulcerative Colitis
      • COVID-19
      • Headache Disorders
      • Neurodegeneration
    • Obesity
      • Breast Cancer
      • Gastrointestinal Cancer
      • Hematologic Cancer
      • Non-small Cell Lung Cancer
      • Prostate Cancer
      • Oncology General
      • Precision Medicine and Diagnostics
      • Axial Spondyloarthritis
      • Systemic Lupus Erythematosus
      • Psoriatic Arthritis
      • Rheumatoid Arthritis
  • Chat Contact Us

Independent Medical Education

Oncology: Hematologic Cancer

Lilly is committed to supporting high-quality education and QI initiatives that provide healthcare professionals (HCPs) with evidence-based, clinically relevant content that advances learners’ knowledge, competence, and performance in order to ultimately impact patient care. We believe quality education is an excellent source to accelerate evidence into practice for the best interest of HCPs and patients. This site shows independent accredited educational activities supported by Lilly via educational grants and targeted for HCPs. All accredited programs must follow the standards set forth in the ACCME Standards for Integrity and Independence in Accredited Continuing Education. All decisions related to the planning, faculty selection, content creation and delivery of accredited education are the sole responsibility of the providers and/or accreditors. Lilly does not support independent education, or any medical activities, for the purpose of encouraging off-label use of our products.

Because the ACCME Standards prohibit us from providing a direct link to the educational activity, you may have to search within the link using the title of the program.

Global ClinicalImpact: Education, Tools, and Resources to Optimize the Care of Patients With Relapsed/Refractory MCL

On-Demand Webcast Activity

Provider: Clinical Care Options, LLC

Virtual Enduring
21-SEP-2022 to 9-APR-2024

Challenges and Changes With Targeted Options in CLL

On-Demand Webinar Activity

Provider: PVI, PeerView Institute for Medical Education, Inc.

Virtual Enduring
24-OCT-2022 to 23-OCT-2023

Transitioning from Chemoimmunotherapy to More Targeted Approaches in MCL

On-Demand Symposium Proceedings Activity

Provider: Medical Learning Institute, Inc.

Virtual Enduring
30-OCT-2022 to 30-OCT-2023

Relapsed/Refractory Mantle Cell Lymphoma and BTK Inhibitors: Expert Exchange and Discussion

On-Demand Webinar Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
24-NOV-2022 to 24-NOV-2023

Relapsed/Refractory Chronic Lymphocytic Leukemia and BTK Inhibitors

On-Demand Webinar Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
25-NOV-2022 to 25-NOV-2023

A Global Perspective on Emerging BTK Inhibitor Therapy Data for Relapsed/Refractory CLL and MCL in 2022

On-Demand Text Module Activity

Provider: Clinical Care Options, LLC

Virtual Enduring
1-DEC-2022 to 30-NOV-2023

Winter Conference Forecast for CLL and MCL: An Expert Exchange on Bruton Tyrosine Kinase Inhibitors

On-Demand Webinar Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
2-DEC-2022 to 2-DEC-2023

The New Climate of Bruton Tyrosine Kinase Inhibitors: Winter Meeting Effects on the Management of CLL and MCL

On-Demand Webinar Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
22-DEC-2022 to 22-DEC-2023

BTK Inhibitors for CLL and MCL: A Settling Storm or Just the Beginning?

On-Demand Discussion Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
28-DEC-2022 to 28-DEC-2023

Application of the Latest Data in CLL/SLL: Guidance for Current and Future Treatment Strategies

On-Demand Text Module Activity

Provider: National Comprehensive Cancer Network, Inc.

Virtual Enduring
11-DEC-2022 to 11-DEC-2023

Application of the Latest Data in CLL/SLL: Guidance for Current and Future Treatment Strategies

On-Demand Symposium Proceedings Activity

Provider: National Comprehensive Cancer Network, Inc.

Virtual Enduring
30-DEC-2022 to 30-DEC-2023

Breakthrough Therapeutics for CLL and Other B-Cell Malignancies: Focus on BTK Inhibitors From Development to Clinical Integration

On-Demand Symposium Proceedings Activity

Provider: Clinical Care Options, LLC

Virtual Enduring
16-DEC-2022 to 15-FEB-2024

Fixing the Target on Aggressive Lymphoma: Guidance on the Next Phase of Integrating Targeted Agents Into MCL and DLBCL

On-Demand Webinar Activity

Provider: The Pennsylvania State University - College of Medicine

Virtual Enduring
30-DEC-2022 to 29-DEC-2023

Elevating Equity in Caring for Patients With Hematologic Malignancies

On-Demand Symposium Proceedings Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
31-DEC-2022 to 31-DEC-2023

Continuing the Conversation: Elevating Equity in Caring for Patients With Hematologic Malignancies

On-Demand Multimedia Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
15-APR-2023 to 15-APR-2024

Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia — What Clinicians Want to Know

On-Demand Symposium Proceedings Activity

Provider: Research to Practice

Virtual Enduring
6-JAN-2023 to 6-JAN-2024

A New Path Forward: The Therapeutic Potential of Next Generation BTK Inhibitors in CLL/SLL

On-Demand Discussion Activity

Provider: The University of Texas MD Anderson Cancer Center - MD Anderson Cancer Center

Virtual Enduring
30-JAN-2023 to 30-JAN-2024

Year in Review — Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Oncology: Chronic Lymphocytic Leukemia Edition

On-Demand Symposium Proceedings Activity

Provider: Research to Practice

Virtual Enduring
2-FEB-2023 to 2-FEB-2024

Real-World Challenges and Solutions with BTKi in CLL: Therapeutic Insights for Community Practice

On-Demand Case Study Activity

Provider: PVI, PeerView Institute for Medical Education, Inc.

Virtual Enduring
6-MAR-2023 to 5-MAR-2024

Advances in Chronic Lymphocytic Leukemia Care: A Master Class for the Community Multidisciplinary Team

On-Demand Multimedia Activity

Provider: Clinical Care Options, LLC

Virtual Enduring
13-MAR-2023 to 12-MAR-2024

Recent Advances and Future Directions in Oncology

On-Demand Webinar Activity

Provider: Research to Practice

Virtual Enduring
18-MAR-2023 to 18-MAR-2024

The Emerging Landscape of BTK Inhibitors for Relapsed/Refractory CLL/SLL: Clinical Practicalities and Perspectives

On-Demand Video Activity

Provider: AXIS Medical Education, Inc.

Virtual Enduring
20-MAR-2023 to 19-MAR-2024

BTK Inhibitors for CLL and MCL: What the Latest Data Mean for Our Patients

On-Demand Discussion Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
21-MAR-2023 to 21-MAR-2024

Relapsed/Refractory Mantle Cell Lymphoma: Where Do Novel BTK Inhibitors Fit for Our Patients?

On-Demand Micro Learning Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
31-MAR-2023 to 31-MAR-2024

Let's Talk Relapsed/Refractory Chronic Lymphocytic Leukemia: Expert Perspectives on Reversible BTK Inhibitors

On-Demand Video Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
17-APR-2023 to 17-APR-2024

Clinical Decision-Making in Relapsed/Refractory Mantle Cell Lymphoma: Test Your Skills

On-Demand Case Study Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
15-JUL-2023 to 15-JUL-2024

Relapsed/Refractory Mantle Cell Lymphoma: How Would You Care for These Virtual Patients?

On-Demand Simulation Activity

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
1-SEP-2023 to 1-SEP-2024

BTKi Breakthroughs: Overcoming Treatment Resistance in CLL & MCL

On-Demand Multimedia Activity

Provider: Forefront Collaborative, Inc. - Forefront Collaborative

Virtual Enduring
31-MAR-2023 to 31-MAR-2024

Crafting the New Treatment Mix in CLL: Pharmacist Insights on Delivering Effective Care With Targeted Therapy

On-Demand Multimedia Activity

Provider: PVI, PeerView Institute for Medical Education, Inc.

Virtual Enduring
21-APR-2023 to 20-APR-2024

Community Practice Connections™: 27th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

On-Demand Recording from a Meeting

Provider: Physicians' Education Resource LLC

Virtual Enduring
30-APR-2023 to 30-APR-2024

Leading Change, Leading Advances in CLL Care: Guidance on Delivering Modern Targeted and Cellular Therapeutics

On-Demand Multimedia Activity

Provider: PVI, PeerView Institute for Medical Education, Inc.

Virtual Enduring
17-MAY-2023 to 16-MAY-2024

The New BTKids on the Block: Compelling Rationale for Non-Covalent Bruton Tyrosine Kinase Inhibition in B-cell Cancers

On-Demand Podcast Activities

Provider: UMA MLG, LLC

Virtual Enduring
31-MAY-2023 to 31-MAY-2024

The New BTKids on the Block: Compelling Rationale for Non-Covalent Bruton Tyrosine Kinase Inhibition in B-cell Cancers

On-Demand Video Activity

Provider: UMA MLG, LLC

Virtual Enduring
20-AUG-2023 to 20-AUG-2024

The New BTKids on the Block: Compelling Rationale for Non-Covalent Bruton Tyrosine Kinase Inhibition in B-cell Cancers

Live Meeting Series

Provider: UMA MLG, LLC

Virtual Live
4-OCT-2023 to 31-OCT-2023

CCO Independent Conference Highlights of the 2023 ASCO Annual Meeting

On-Demand Recording from a Meeting

Provider: Clinical Care Options, LLC

Virtual Enduring
1-JUN-2023 to 27-JUL-2024

The Evolving Landscape in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Best Practice Clinical Applications of Current Evidence and New Guideline Recommendations

On-Demand Multimedia Activity

Provider: National Comprehensive Cancer Network, Inc.

Virtual Enduring
2-JUN-2023 to 2-JUN-2024

The Evolving Landscape in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Best Practice Clinical Applications of Current Evidence and New Guideline Recommendations

On-Demand Webcast Activity

Provider: National Comprehensive Cancer Network, Inc.

Virtual Enduring
31-JUL-2023 to 30-JUL-2024

Meet The Professors Live: Clinical Investigators Provide Perspectives on Actual Cases of Patients with Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma

On-Demand Symposium Proceedings Activity

Provider: Research to Practice

Virtual Enduring
2-JUL-2023 to 2-JUL-2024

Exploring the Advancements in BTK Inhibitor Therapy for Mantle Cell Lymphoma and the Growing Impact of Oncology Pharmacists

On-Demand Webinar Activity

Provider: Pharmacy Times Office of Continuing Professional Education LLC

Virtual Enduring
17-JUL-2023 to 17-JUL-2024

Targeted Therapeutics in CLL and MCL: Applying Emerging BTK Inhibitor Therapy Data to Practice

On-Demand Video Activity

Provider: Clinical Care Options, LLC

Virtual Enduring
17-JUL-2023 to 27-FEB-2025

Oncology Today with Dr Neil Love — Role of BTK Inhibitors in Patients with Mantle Cell Lymphoma Edition: A CME Series Focused on Research and Management Issues Across the Oncology/Hematology Continuum

On-Demand Multimedia Activity

Provider: Research to Practice

Virtual Enduring
24-JUL-2023 to 24-JUL-2024

Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences

On-Demand Multimedia Activity

Provider: Research to Practice

Virtual Enduring
22-AUG-2023 to 22-AUG-2024

Current Advances in Relapsed/Refractory MCL: Expert Guidance for Community Hematology Care Teams

On-Demand Webcast Activity

Provider: Clinical Care Options, LLC

Virtual Enduring
31-AUG-2023 to 30-AUG-2024

Mantle Cell Lymphoma: Novel Therapeutic Strategies Using the New Generation of BTK Inhibitors

On-Demand Multimedia Activity

Provider: Clinical Care Options, LLC

Virtual Enduring
13-SEP-2023 to 23-OCT-2024

2023 Oncology State Societies at ACCC Meeting Series – Community Oncology Connections™: Integrating BTK Inhibitors Into the CLL /SLL and MCL Treatment Paradigm: Considerations for Community Practitioners

Live Meeting Series

Provider: Physicians' Education Resource LLC

Virtual Live
15-SEP-2023 to 23-DEC-2023

CCO at iwCLL 2023 Symposium - Expert Roundtable on the Current and Near Future Impact of Novel Therapeutic Options for Relapsed/Refractory CLL/SLL

Live Symposium

Provider: Clinical Care Options, LLC

In-Person- Satellite Symposium
16-NOV-2023

2023 ASH FSS – Medical Crossfire®: Novel BTKi Strategies Transforming Aggressive and Indolent B-Cell Malignancies

Live Symposium

Provider: Physicians' Education Resource LLC

In-Person- Satellite Symposium
8-DEC-2023

Beyond The Guidelines: Clinical Investigator Perspectives on the Management of Patients with Chronic Lymphocytic Leukemia —A Friday Satellite Symposium Preceding the 65th American Society of Hematology (ASH) Annual Meeting

Live Symposium

Provider: Research to Practice

In-Person- Satellite Symposium
8-DEC-2023

Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Live Symposium

Provider: National Comprehensive Cancer Network, Inc.

In-Person- Satellite Symposium
8-DEC-2023

(ASH 2023) Controlling & Conquering the Challenge of CLL: Real-World Guidance on Upfront & Sequential Targeted Choices, Innovative Combinations, and Immunotherapy

Live Symposium

Provider: The Pennsylvania State University - College of Medicine

In-Person- Satellite Symposium
8-DEC-2023


  • Copyright
  • Terms of Use
  • Privacy Statement
  • Accessibility Statement
  • Sitemap

To speak to customer support:
Call (XXX) XXX-XXXX

This site is intended for US Healthcare Professionals only.

4.3.2 08/2023 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2023. All rights reserved.

Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

Facebook Twitter LinkedIn
Lilly